BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30842144)

  • 1. Minichromosome Maintenance Proteins MCM-3, MCM-5, MCM-7, and Ki-67 as Proliferative Markers in Adrenocortical Tumors.
    Aporowicz M; Czopnik P; Kubicka E; Piotrowska A; Dziegiel P; Bolanowski M; Domoslawski P
    Anticancer Res; 2019 Mar; 39(3):1151-1159. PubMed ID: 30842144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex.
    Szajerka A; Dziegiel P; Szajerka T; Zabel M; Winowski J; Grzebieniak Z
    Anticancer Res; 2008; 28(5B):2959-65. PubMed ID: 19031940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas.
    Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Maj J; Dziegiel P
    Anticancer Res; 2015 Nov; 35(11):6017-26. PubMed ID: 26504025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weineke criteria, Ki-67 index and p53 status to study pediatric adrenocortical tumors: Is there a correlation?
    Das S; Sengupta M; Islam N; Roy P; Datta C; Mishra PK; Banerjee S; Chaudhuri MK; Chatterjee U
    J Pediatr Surg; 2016 Nov; 51(11):1795-1800. PubMed ID: 27567308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Immunohistochemical Expression of MCM-3, -5, and -7 Proteins in the Uterine Fibroids.
    Rubisz P; Hirnle L; Kobierzycki C
    Curr Issues Mol Biol; 2021 Jul; 43(2):802-817. PubMed ID: 34449552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of MCM-2 and MCM-5 expression in colon cancer: association with clinicopathological parameters and tumor proliferative capacity.
    Giaginis C; Georgiadou M; Dimakopoulou K; Tsourouflis G; Gatzidou E; Kouraklis G; Theocharis S
    Dig Dis Sci; 2009 Feb; 54(2):282-91. PubMed ID: 18465232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone mRNA in situ hybridization and Ki 67 immunohistochemistry in pediatric adrenocortical tumors.
    Orhan D; Kale G; Cağlar M; Göğüş S; Karaağaoğlu E
    Virchows Arch; 2006 May; 448(5):591-6. PubMed ID: 16489441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between immunohistochemical expression of Ki-67 and MCM-3 in major salivary gland epithelial tumors in children and adolescents. Preliminary study.
    Zieliński R; Kobos J; Zakrzewska A
    Pol J Pathol; 2016; 67(4):351-356. PubMed ID: 28547962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of cell proliferation markers (Minichromosome maintenance protein 7, topoisomerase IIalpha and Ki-67) in cavital fluid cytology: can we differentiate reactive mesothelial cells from malignant cells?
    Kimura F; Kawamura J; Watanabe J; Kamoshida S; Kawai K; Okayasu I; Kuwao S
    Diagn Cytopathol; 2010 Mar; 38(3):161-7. PubMed ID: 19821496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.
    Kiiveri S; Liu J; Arola J; Heikkilä P; Kuulasmaa T; Lehtonen E; Voutilainen R; Heikinheimo M
    Mol Cell Endocrinol; 2005 Apr; 233(1-2):47-56. PubMed ID: 15767045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms.
    Nakazumi H; Sasano H; Iino K; Ohashi Y; Orikasa S
    Mod Pathol; 1998 Dec; 11(12):1165-70. PubMed ID: 9872646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of histological and immunohistochemical patterns of benign and malignant adrenocortical tumors by computerized morphometry.
    Dalino Ciaramella P; Vertemati M; Petrella D; Bonacina E; Grossrubatscher E; Duregon E; Volante M; Papotti M; Loli P
    Pathol Res Pract; 2017 Jul; 213(7):815-823. PubMed ID: 28554744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MCM-2 and MCM-5 expression in gastric adenocarcinoma: clinical significance and comparison with Ki-67 proliferative marker.
    Giaginis C; Giagini A; Tsourouflis G; Gatzidou E; Agapitos E; Kouraklis G; Theocharis S
    Dig Dis Sci; 2011 Mar; 56(3):777-85. PubMed ID: 20694513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma.
    Romero Arenas MA; Whitsett TG; Aronova A; Henderson SA; LoBello J; Habra MA; Grubbs EG; Lee JE; Sircar K; Zarnegar R; Scognamiglio T; Fahey TJ; Perrier ND; Demeure MJ
    Ann Surg Oncol; 2018 Mar; 25(3):801-807. PubMed ID: 29218429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of Ki-67 and MCM-2 proliferative marker expression with grade of histological malignancy (G) in ductal breast cancers.
    Wojnar A; Kobierzycki C; Krolicka A; Pula B; Podhorska-Okolow M; Dziegiel P
    Folia Histochem Cytobiol; 2010 Sep; 48(3):442-6. PubMed ID: 21097442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients.
    Coli A; Asa SL; Fadda G; Scannone D; Chiloiro S; De Marinis L; Lauretti L; Ranelletti FO; Lauriola L
    Eur J Endocrinol; 2016 Mar; 174(3):307-14. PubMed ID: 26620390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas.
    Morimoto R; Satoh F; Murakami O; Suzuki T; Abe T; Tanemoto M; Abe M; Uruno A; Ishidoya S; Arai Y; Takahashi K; Sasano H; Ito S
    Endocr J; 2008 Mar; 55(1):49-55. PubMed ID: 18187873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic utility of SF-1 in adrenal cortical tumours.
    Maity P; Mondal A; Das R; Sengupta M; Gargari P; Kar A; Sarkar D; Mukhopadhyay S; Chowdhury S; Chatterjee U
    Indian J Pathol Microbiol; 2022; 65(4):814-820. PubMed ID: 36308186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours.
    Schmitt A; Saremaslani P; Schmid S; Rousson V; Montani M; Schmid DM; Heitz PU; Komminoth P; Perren A
    Histopathology; 2006 Sep; 49(3):298-307. PubMed ID: 16918977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MCM3: A Novel Proliferation Marker in Oral Squamous Cell Carcinoma.
    Valverde LF; de Freitas RD; Pereira TA; de Resende MF; Agra IMG; Dos Santos JN; Dos Reis MG; Sales CBS; Gurgel Rocha CA
    Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):120-125. PubMed ID: 27258565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.